Measuring and Predicting Response to Atomoxetine and Methylphenidate

Trial Profile

Measuring and Predicting Response to Atomoxetine and Methylphenidate

Recruiting
Phase of Trial: Phase III

Latest Information Update: 01 Jul 2017

At a glance

  • Drugs Atomoxetine (Primary) ; Methylphenidate (Primary)
  • Indications Attention-deficit hyperactivity disorder
  • Focus Therapeutic Use
  • Most Recent Events

    • 27 Feb 2008 New trial centres added.
    • 07 Nov 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top